
Investing.com -- Stocks were headed higher as investors await clarity on the outcome of debt ceiling negotiations in Washington. Here are the market movers for May 15.
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares jumped 28% after expert outside advisors to the Food and Drug Administration recommended approval for its muscular dystrophy gene therapy.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.